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Neonatal development of the rat testis involves a number of critical events including re-entry of gonocytes into the cell cycle and eventual
loss of many of these cells and their progeny via apoptosis. Since surviving gonocytes give rise to subsequent generations of germ cells,
regulation of their fate is critical for adult testicular function. Here, we have identified a role for short-type PB-cadherin (STPB-C) in
promoting survival of gonocytes in neonatal rats and we have linked its expression to the JAK-STAT signaling pathway. These findings were
obtained with varied approaches including use of transgenic rats overexpressing STPB-C which were studied with protein microarrays and
other techniques, direct examination of germ cell apoptosis and survival in gonocyte–Sertoli cell co-cultures, and direct study of the JAK-
STAT pathway in these models and in L cells transfected with STPB-C. These data provide new information on the regulation of gonocyte
fate and exciting new evidence supporting a link between the JAK-STAT pathway and cadherin-based cell–cell interactions.
D 2005 Elsevier Inc. All rights reserved.Keywords: Neonatal gonocytes; STPB-C; Cadherin; Survival; JAK-STAT pathwayIntroduction
Perinatal development of testes in male rodents is critical
in establishing spermatogenesis and thus in insuring fertility
of the adult animal. At birth, the germ cell population is
comprised exclusively of gonocytes, some of which give
rise to all subsequent generations of germ cells. Gonocytes
re-enter the cell cycle on post-natal day 3 and assume their
proper position at the basal lamina during the subsequent
several days (McGuinness and Orth, 1992). The ensuing
proliferative activity among the gonocytes and early
spermatogonia is accompanied by a substantial level of
apoptosis (Rodriguez et al., 1997), during which a critical
degree of culling occurs to insure a germ cell population of
appropriate size. Regulation of apoptosis among these germ
cells is thought to involve regulation of various, well-
recognized genes such as Bax and Bcl-2 variants (Knudson
et al., 1995; Furuchi et al., 1996). However, it remains0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.05.042
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E-mail address: orthjo@temple.edu (J.M. Orth).unclear how expression of these and other genes is modified
so that gonocytes which are destined to give rise to
spermatogonia avoid apoptosis and survive.
Survival of gonocytes is likely, at least in part, to depend
on maintenance of proper associations between these cells
and Sertoli cells. Many events that occur throughout
development require critical germ cell–Sertoli cell interac-
tions such as maintenance of physical attachment between the
cells, metabolic support of germ cells by Sertoli cells, and
expression of various factors by one or both cells (Griswold,
1995; Orth et al., 2000). In our earlier work, we identified a
novel adhesion molecule in the testis, short-type PB-cadherin
(STPB-C), and found that it has a specific spatial and
temporal expression pattern (Wu et al., 2003). It is highly
expressed by gonocytes and Sertoli cells of neonates, with
STPB-C mRNA levels maximal during the first post-natal
week and declining by day 10. Subsequently, STPB-C
remains at low levels throughout adulthood. This pattern of
expression suggests a potential role for this cadherin in post-
natal development of the testis. Interestingly, unlike most
cadherins, STPB-C lacks an intracellular catenin-binding284 (2005) 437 – 450
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does not involve interaction with cytoskeletal elements and
that its function may extend beyond that of classical adhesion
molecules. To date, no information beyond our previous
findings is available regarding this unusual testicular
cadherin and its potential function.
Our goals in the current study were first, to determine
whether the level of STPB-C affects gonocyte numbers and,
potentially, their survival in neonates and second, to identify
some of the subcellular mechanisms involved in STPB-C
function. To this end, we used varied approaches, including
developing and studying transgenic rats overexpressing
STPB-C, assessing the effect of its blockade in primary
co-cultures from testes of newborn rats, and examining the
effect of transfecting cadherin-negative L cells with STPB-
C. Our findings support a role for this cadherin in
suppressing gonocyte apoptosis, suggesting that STPB-C
may be important in determining the fate of these cells. In
addition, findings from other experiments identified a link
between expression of STPB-C and the Janus kinase-signal
transducer and activator of transcription (JAK-STAT)
signaling pathway. We identified JAK2 and/or SH2B as
STPB-C binding partners and demonstrated that STPB-C
induces phosphorylation of JAK2 and STAT3. Thus, STPB-
C appears to promote survival of germ cells in neonates and
acts via the JAK-STAT pathway. Linking STPB-C to the
JAK-STAT pathway is a novel observation previously
unreported for any member of the cadherin family.Materials and methods
Constructs
A 2.1 kb fragment containing the total open reading
frame of short-type PB-cadherin (STPB-C) and a Kozak
sequence (Genscript Corp., Edison, NJ) was cloned into
pCMV-script vector (Stratagene, La Jolla, CA) (pCMV-
STPB-C) for transfection studies, or the fragment was
cloned into the proprietary StealthGene vector for trans-
genesis (StealthGene-STPB-C; Tosk, Inc., Santa Cruz, CA).
Generation of STPB-C transgenic rats
All animal work was carried out under the National
Institutes of Health guidelines and all animals were Sprague–
Dawley rats (Charles River Breeding Labs, Kingston, RI).
Mosaic founders of transgenic rats (Tgs) were produced by
Tosk, Inc. (Santa Cruz, CA) using a proprietary process
involving combining the STPB-C gene with the Tosk
‘‘StealthGene’’ vector. In general, mosaic founders were
produced at the Tosk facility by injecting STPB-C-Stealth-
Gene vector into adult rats, where 20–40% of cells are
randomly transformed with 1–3 copies of the transgene/cell,
including some germ cells (per Tosk, Inc.). Since transposase
is targeted for degradation, all StealthGene integrations arestabilized. Founder rats were mated to wild-type animals and
heterozygotic transgenic progeny were identified by Tosk,
Inc. via Southern blotting. These transgenic progeny were
mated in our facility, where we characterized the offspring by
confirming the presence and stability of the transgene, as
follows. First, real-time PCR was carried out to identify Tg
lines with different StealthGene vector copy numbers. Next,
we used Southern blotting to confirm the resulting transgenic
lines and to quantify copy number for transgenic STPB-C.
Finally,Western analysis was used to confirm overproduction
of STPB-C protein in the transgenics. These analyses are
described below.
Real-time PCR
Genomic DNA was extracted from rat tails with the
DNeasy Tissue kit according to the manufacturer’s instruc-
tions (QIAGEN, Valencia, CA), and the real-time PCR
procedure was carried out using a SmartCycler (Cepheid,
Sunnyvale, CA). The primers used for amplification of the
StealthGene vector were provided by Tosk, Inc. and were:
sense, 5V-GTGGGAGCAGAGCCTTGGGTGCAG-3V; anti-
sense, 5V-CTAGGTACGGCATCTGCGTTGAGTCG-3V.
Real-time PCR was carried out in a total volume of 20 Al,
each reaction containing 2 Al LightCycler-DNA Master
SYBR Green 1 (Roche, Indianapolis, IN), 250 ng of
template DNA, 4 mM Mgcl2, and 0.5 AM of each primer.
The standard curves generated by this procedure contained
the equivalent of 0.0625–1 Ag DNA input/tube. The real-
time PCR program consisted of an initial hold at 95-C for
120 s to denature the genomic double-stranded DNA,
followed by 40 cycles of 15 s at 95-C and 20 s at 69-C.
Southern blotting
Genomic DNA was isolated from rat tails as described
above and digested with BclI and HincII. Samples were
loaded onto 0.7% agarose gel along with molecular weight
markers and run at 35 V for 10 h. These samples were then
depurinated in 0.2 M HCl for 10 min, denatured in 0.5 M
NaCl/0.5 M NaOH for 45 min, and neutralized in 1.5 M
NaCl/1.0 M Tris–Cl (pH 7.4) for 15 min. After neutraliza-
tion, DNAs were transferred by capillary action to a nylon
membrane (Amersham Pharmacia Biotech, Arlington
Heights, IL). Hybridization was carried out with a probe
homologous to exon 6 of the STPB-C gene. Prehybridization,
hybridization, and subsequent washings were performed as
described previously and copy numbers were quantified on
resulting blots with densitometry (Wu et al., 2003).
Gonocyte–Sertoli cell co-cultures and anti-STPB-C
treatment
Gonocytes–Sertoli cell co-cultures were prepared as
previously described (Orth and Boehm, 1990). Briefly,
Sertoli cells and gonocytes were isolated from testes of 2-
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with collagenase/hyaluronidase and collagenase. After incu-
bating cell aggregates in cell dissociation buffer (Life
Technologies, Inc., Gaithersburg, MD), the resulting single
cell suspension was plated on growth-factor-depleted Matri-
gel (Collaborative Research, Waltham, MA) in either 35 mm
plastic pertri dishes or eight-chamber culture slides (Lab-Tek-
Nunc, Naperville, IL). Gonocyte–Sertoli cell co-cultures
were maintained in hormone- and serum-free Eagle’s D-
valine MEM (Sigma, St Louis, MO) with supplements in a
5% CO2 atmosphere at 37-C for up to 32 h. One day after
plating, the co-cultures were exposed to anti-STPB-C (Wu et
al., 2003) (5 ng/Al, Resgen, Huntsville, AL) or preimmune
serum (negative control) in the presence of Chariot Reagent
(Activemotif, Carlsbad, CA) to facilitate penetration of the
antisera into the cells. Additional cultures were exposed to h-
galactosidase under similar conditions as a positive control
for cell penetration and to provide a measure of penetration
efficiency (68%) after staining for the enzyme. For Western
blot analysis, cells were scraped from the dishes at 15 min–
32 h after treatment, rinsed and frozen, followed by isolation
of protein as described below. For morphology, co-cultures in
chamber culture slides (3 slides/group) were observed with
phase-contrast optics 1 day post-treatment, and then fixed.
For each slide, the number of gonocytes adherent to the
confluent Sertoli cell monolayer was counted under 60
magnification in each of 30–50 contiguous visual fields,
using an eyepiece grid and beginning in the upper left corner
of each slide. The totals were expressed as the mean number
of gonocytes/field and the Student’s t test was applied to the
data.
Antibody microarrays
We used antibody microarray analysis to identify
potential candidate proteins that might be over- or under-
expressed in Tg vs. wild-type rats. For this, testes obtained
from transgenic rat pups (4 days old) or age-matched
controls were decapsulated, snap-frozen in liquid nitrogen,
and stored at 80-C until extraction of protein. Total protein
from these testes was extracted and antibody microarray
analysis was used with a BD Clontech Ab Microarray kit
following the manufacturer’s protocol (BD Biosciences
Clontech, Palo Alto, CA). Protein concentrations were
determined using a BCA protein Assay Reagent Kit (Pierce,
Rockford, IL). Protein was labeled using Cy3 and Cy5
mono-Reactive Dye (Amersham Biosciences, Piscataway,
NJ) and purified away from free dye using PD-10 Desalting
Columns (Amersham Biosciences, Piscataway, NJ). The
microarray slides were scanned with a GenePix 4000 B
instrument (Axon Instruments, Union City, CA) and
subsequent data analysis was carried out according to the
manufacturer’s directions, as follows. GenePix Pro 4.0
microarray analysis software (Axon Instruments) was used
to obtain Cy5/Cy3 fluorescent signal ratios for all coor-
dinates and the Ab Microarray Analysis Workbook (BDBiosciences Clontech) was used to convert these data into
Internally Normalized Ratios (INRs). For each coordinate,
an INR (transgenic/control) greater than or equal to 2.0 was
considered to represent increased expression, whereas a
ratio less than or equal to 0.5 was considered to represent
decreased expression.
Immunoprecipitation and Western blotting
Protein from testes or cells was extracted as described
above and Western blotting or immunoprecipitation was
performed as described previously (Orth et al., 1996), with
some modifications. For Western blotting, membranes were
exposed to anti-p-JAK2 (phosphorylated Janus activated
kinase 2, 1:100, Santa Cruz Biotechnology, Inc., Santa
Cruz, CA), anti-JAK2 (1:200, Santa Cruz Biotechnology,
Inc.), anti-p-STAT3 (phosphorylated Signal Transducer and
Activator of Transcription 3, 1:100, Santa Cruz Biotechnol-
ogy, Inc.), anti-STAT3 (1:1000, BD Bioscience Clontech),
anti-STAT5 (1:200, BD Bioscience Clontech), anti-SH2-B
(1:100, BD Bioscience Clontech), or anti-STPB-C (1:200,
Resgen). For immunoprecipitation, protein samples were
first pre-cleared in 1% normal rabbit serum for 1 h at 4-C
followed by addition of protein A-agarose for an additional
hour and centrifugation. Supernatant was then incubated
with anti-STPB-C (Resgen) for 2 h at 4-C, followed by
addition of protein A-agarose and overnight incubation. The
immunoprecipitate was collected by centrifugation, washed
with extraction buffer (BD Bioscience Clontech), resus-
pended in sample buffer, and separated by electrophoresis as
described previously (Orth et al., 1996) for Western
analysis. Membranes were immunodetected with appropri-
ate antibodies to anti-STPB-C (1:200, Resgen, positive
control), anti-SH2-B (src homology 2-B, 1:100, BD Bio-
science Clontech), anti-JAK2 (1:200, Santa Cruz Biotech-
nology, Inc.), or pre-immune serum (negative control).
Morphological analysis and TUNEL reaction
For comparison of Tg (n = 6) and wild-type (n = 9) pups,
body and testis weights were determined on post-natal day 4
by direct measurement. Testes from both groups (n = 3/
group) were then fixed in 4% paraformaldehyde, embedded
in paraffin, sectioned, and then cleared by routine methods.
For morphological analysis, sections were stained in 1%
Toluidine Blue in 1% Na Borate and seminiferous cord
diameters and number of gonocytes/cord profile were
determined as described previously (McGuinness and Orth,
1992). For the TUNEL reaction, additional sections were cut
and subjected to proteinase K digestion (20 Ag/ml, 15 min,
RT), followed by incubation at 37-C for 60 min in a TdT
(terminal deoxynucleotidyl transferase) cocktail containing 1
mM dATP (Sigma, St. Louis, MI), 0.25 units TdT/Al
(Promega, Madison, WI), and 6 AM biotin-11-dUTP
(Perkin-Elmer, Branchburg, NJ) in One-Phor-All Buffer
(Amersham/Pharmacia, Piscataway, NJ). After washing,
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tion in a suppression solution (Pierce Chemical, Rockford,
IL ) for 15 min at RTand positive nuclei were visualized with
a Histostain-SP Kit using a red AEC chromogen, per the
manufacturer’s directions (Zymed Labs, San Francisco, CA).
For each animal, 20 sections were examined, each section
containing a minimum of 5 cross-sectioned cords (3–5
gonocytes/cord profile). Thus, 300–500 gonocytes were
assessed in each rat for the presence or absence of reaction.
Representative sections were photographed with a Leitz
Orthoplan microscope equipped with a Magna-Fire digital
camera (Optronics, Inc., Muskogee, OK).
Immunolocalization
Gonocyte–Sertoli cell co-cultures prepared on day 2
after birth were treated with either anti-STPB-C (5 ng/Al) or
pre-immune serum in the presence of the Chariot reagent as
already described and then fixed with 4% paraformaldehyde
(15 min, RT) at 4, 10, or 21 h after treatment. Routine
methods were used to immunolocalize Caspase-3 in
chambers from both groups, as follows. After rinsing and
then permeabilizing in ice-cold methanol, cultures were
incubated in blocking solution (10% NGS in PBS, 60 min
RT), followed by rinsing and overnight incubation in
primary antibody at 4-C (Rabbit polyclonal Anti-Caspase-
3, dil 1:100; Chemicon, Temecula, CA). After extensive
rinsing, co-cultures were incubated in darkness with rhod-
amine-conjugated secondary antibody (Goat anti-rabbit IgG,
dil 1:500, 1 h 4-C; Jackson Immunoresearch, West Grove,
PA), then rinsed, mounted in DAPI-containing medium, and
viewed and photographed with a Nikon inverted microscope
equipped with a Magna-Fire digital camera (Optronics Inc.,
Muskogee, OK).
L cell culture and transfection
L cells were cultured at 37-C in a complete medium
(Eagle’s minimum essential medium with 2 mM l-
glutamine and Earle’s BSS, 0.1 mm non-essential amino
acids, and 1.0 mm sodium pyruvate, 10% horse serum,
100u/ml penicillin, 100 Ag/ml streptomycin) and transfected
with pCMV-STPB-C or empty pCMV vector, using a
calcium phosphate transfection kit (Invitrogen, Carlsbad,
CA). Stably transfected cell lines were selected for
resistance to neomycin (G418, 400 Ag/ml, Invitrogen) for
more than 20 days in vitro. Individual clones were screened
by semi-quantitative RT-PCR and clones exhibiting high
expression of STPB-C mRNA were used to assay for cell
aggregation and for expression of JAK2, STAT3, p-JAK2,
and p-STAT3.
Semiquantitative RT-PCR
Total RNAwas isolated from cells transfected with either
pCMV-STPB-C or empty vector (mock) using the QiagenRNeasy kit according to the manufacturer’s instructions
(Qiagen). cDNAwas synthesized by reverse transcription of
1.5 Ag total RNA using an oligo(dT)12–18 primer (Invi-
trogen) with superscript II RNase H reverse transcriptase
(Invitrogen). PCR was carried out in a volume of 50 Al
containing 10 Al reverse transcriptase reaction mixture, 1
PCR buffer, 1.5 mM magnesium chloride, 200 AM of dNTP
mix, 200 nM of each primer (50 nM of each primer for
GAPDH), and 2 U Taq polymerase (Invitrogen). Primers
were designed according to published sequences of the rat
STPB-C mRNA (accession number D83349) or the rat
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH)
mRNA (accession number M17701). Primer sequences for
STPB-C were: sense, 5V-TTACTGTGTTGGCCATGGAA-
3V; antisense, 5V-GTTGCTGGGTTCCTCTGGTA-3V, yield-
ing a product of 236 bp; PCR was performed using the
following temperature cycle profile: 3 min at 94-C,
followed by 30 cycles of 30 s at 94-C, 1 min at 58-C, 42
s at 72-C, and 10 min at 72-C. PCR products were subjected
to horizontal agarose gel electrophoresis. Amplification
products were eluted, subcloned into pCR Blunt-TOPO
(Invitrogen), and sequenced for verification. As a control,
PCR was performed simultaneously for both GAPDH and
STPB-C. Primers for GAPDH were: sense, 5V-CCCATCA-
CCATCTTCCAGGAGC-3V, antisense, 5V-AGAGCAATG-
CCAGCCCCAGC-3V, yielding a product of 692 bp.
Northern blotting
Total RNA was extracted as described above for
semiquantitative RT-PCR. Samples (10 Ag RNA/lane)
were run on a 1% agarose-formaldehyde gel and trans-
ferred by capillary action to a nylon membrane (Amer-
sham Pharmacia Biotech) in 20 SSC overnight.
Prehybridization and hybridization were done as described
above for Southern blotting, with reagents supplied in the
kit used at recommended concentrations. The probe was a
Kpn1–Sac1 fragment (1327 bp) containing STPB-C
cDNA (1225 bp), produced as described previously (Wu
et al., 2003).
Cell aggregation assay
The cell aggregation assay was performed five times as
described by others (Takeichi, 1977) with modifications. A
suspension of 5  105 L cells was incubated for 25 min at
37-C, with or without 1 mM CaCl2 on a gyro-shaker at 80
rpm. After incubation, the number of aggregated particles in
the cell suspension was measured, and the ratio of particles
to initial cell number was calculated.
Statistical analysis
All experiments were repeated 3–5 times, findings
quantified as appropriate to the experiment, and means
determined for each sample group. For each experiment, the
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between mean values obtained for control and treatment
groups.Results
Transgenic rats overexpress STPB-C
To study the role of STPB-C in male germ cell
development, we produced transgenic rats overexpressing
STPB-C (Tgs) by using a novel approach to generateFig. 1. Establishment of a transgenic rat model overexpressing STPB-C. (A) Rea
standard curve generated by amplification, containing the equivalent of 0.0625–1
tails. Red arrowhead, positive control; blue arrowhead, negative control. Two line
higher copy number, line 2 with apparently lower copy number by the yellow arrow
recognizing exon 6 of the STPB-C genomic sequence. DNAwas digested with Bcl
3, negative rat. Densitometric analysis indicates that line 1 has 5 copies of the tran
obtained from line 1 neonatal transgenic (Tg) or control rats (Con), to confirm o
Western blots from 5 separate experiments were quantified by densitometry and the
Tg rats express approximately twice the normal amount of STPB-C. *P < 0.05.mosaic rat founders carrying StealthGene-STPB-C in
some germ cells. Tg offspring were identified as follows.
First, the StealthGene vector was amplified with real-time
PCR and two transgenic lines were identified, one with
higher copy number than the other (Fig. 1A,b, pink and
yellow arrows, respectively). Next, Southern analysis was
carried out and the transgene identified in samples from
each of the two Tg lines with a probe recognizing exon 6
of the STPB-C genomic sequence (Fig. 1B). Quantitative
densitometric analysis indicated that these two transgenic
lines have 3 (lane 1) and 5 (lane 2) copies of the
transgene. Finally, Western blot analysis was performedl-time PCR data as used to identify STPB-C transgenic rats. (a) A typical
mg DNA input/tube. (b) Amplification profiles of genomic DNA from rat
s of transgenic rats are indicated, line 1 by the pink arrow with apparently
(green arrow, negative rat). (B) Southern blotting of tail DNAwith a probe
I and HincII. Lanes 1 and 2: transgenic rats, lines 2 and 1, respectively; lane
sgene [not shown]. (C) Representative Western analysis of testicular protein
verexpression of STPB-C in 2-day-old and 4-day-old transgenic pups. (D)
data were expressed as a ratio of STPB-C:h-tubulin (means T SEM). Line 1
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neonatal Tgs on days 2 and 4 after birth (Figs. 1C,D).
For all subsequent analyses, we used the Tg line with 5
copies of the transgene. Based on our earlier finding in
normal rats that STPB-C expression is high in neonates
and low in adults (Wu et al., 2003), we focused our
initial analyses of Tgs on post-natal day 4 (Fig. 2). Testis
weights in neonatal Tgs tended to be higher than in
controls, but this difference was not significant, nor were
seminiferous cord diameters altered. However, the number
of gonocytes per cross-sectioned seminiferous cord in Tgs
was more than two times that seen in controls (P <
0.001), suggesting that overexpression of STPB-C may
increase production and/or survival of gonocytes. In a
preliminary analysis of adult transgenic rats, Tg rats were
mated and the outcome compared to that from matings
between wild-type rats. Both litter frequency and litter
sizes were similar in the two groups. In addition, routine
examination indicated that testes of adult Tgs were
generally normal in morphology, with all stages of the
spermatogenic cycle represented and abundant mature
spermatids present in the lumens of many tubules.
Finally, when serum FSH, LH and triiodothyronine wereFig. 2. (A) Representative morphology of testes from 4-day-old transgenic rats, d
many gonocytes present (a and b). As would be expected on day 4, gonocytes mov
two examples are indicated by arrows at higher magnification in panel c. Scale bar
weights (a) and cord diameters (b) were similar in transgenics and controls. How
transgenics (Tg) compared to controls (Con). *P < 0.001.measured and compared between the groups, no signifi-
cant differences were identified (data not shown).
STPB-C promotes survival of gonocytes in vivo and in vitro
To determine if our finding of higher numbers of
gonocytes in Tg pups reflects enhanced survival of these
cells, the TUNEL reaction was used to compare gonocyte
apoptosis in vivo between 4-day-old control and Tg rats
(Fig 3A). In normal animals, occasional TUNEL-positive
gonocytes were routinely encountered within the semi-
niferous cords in virtually all of the sections examined. In
Tgs, however, no TUNEL-positive cells were seen in any
of the 20 sections examined for each of three pups,
suggesting that overexpression of STPB-C may suppress
gonocyte apoptosis. To examine this possibility directly,
we tested the effect of STPB-C antiserum on normal
gonocytes co-cultured under standard conditions in vitro
(Fig. 3B). Gonocyte–Sertoli cell co-cultures were treated
with either anti-STPB-C or pre-immune serum in the
presence of the Chariot reagent to facilitate entry of the
antiserum into the cells. After 24 h, it was obvious upon
visual inspection of cultures exposed to STPB-C anti-emonstrating that the overall morphology of testicular cords is normal with
ing towards or already in contact with the basement membrane are common;
= 20 Am. (B) Morphometric analysis of transgenic and control testes. Testis
ever, significantly higher numbers of gonocytes/cord (c) were quantified in
Fig. 3. The role of STPB-C in gonocyte apoptosis in vivo and in vitro. (A) Representative views 4-day-old testis sections from Tg pups and control pups
subjected to the TUNEL reaction. Occasional positive gonocytes were seen in controls (a), while no apoptotic cells were detected within the seminiferous
cords of any of the sections examined from Tg pups (b). (B) The effect of anti-STPB-C treatment on gonocyte survival in vitro. Gonocyte–Sertoli cell co-
cultures from normal 4-day-old pups were exposed for 24 h to either pre-immune serum (a) or STPB-C antiserum (b), both in the presence of the Chariot
reagent to facilitate entry of antiserum into the living cells. Examples of gonocytes either rounding up or floating are indicated by arrows. Note the
obviously higher number of detaching cells in the antiserum-treated culture. Small inset: Gonocyte showing typical nuclear morphology with several
nucleoli. (C) The number of gonocytes remaining adherent was quantified and compared between anti-STPB-C-treated and control co-cultures 24 h after
start of the experiment. Approximately twice as many gonocytes remained in control vs. treated cultures (mean T SEM, n = 3 experiments; *P < 0.02). (D)
The effect of anti-STPB-C treatment on expression of caspase-3 in co-cultured gonocytes. Cultures were exposed to either pre-immune serum (a,b) or to
anti-STPB-C (c,d) on the day after plating and then fixed 10 h later. (a,c) DAPI immunofluorescence. (b,d) Caspase-3 immunofluorescence. Note the
obvious increase in caspase-3 positive cells in anti-STPB-C treated cultures. Judged by their size and position, most if not all of the immunopositive
apoptotic cells in these cultures are gonocytes. Scale bar = 20 Am.
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Table 1
Expression of proteins in testicular samples of 4-day-old transgenic rats
compared to controls
Name Swiss prot
accession #
Fold increase
over controls
PI-3 kinase (p110a) P42336 2.17
Nestin P48681 2.01
Neuroglycan C O95196 2.20
HAX-1 O00165 2.07
c-Myc P01106 2.74
CD3z P20963 2.28
PKC lambda n/a 2.01
Endothelin receptor P25101 2.15
Synaptophysin P08247 2.19
Stat 3 P40763 3.07
Ikka/1 O15111 2.79
Calretinim P22676 2.07
CDC27 P30260 2.17
CrmA P07385 2.05
Bog O75884 3.46
TLS P35637 2.16
NFAT-1 Q13469 2.01
PU.1 (Spi-1) P17947 2.08
PKArIIb P31323 2.06
Gap1m Q15283 2.35
Amphiphysin P49418 2.07
FBF Q12828 2.34
Fnk Q9H4B4 2.79
MUPPI O75970 2.46
Serotonin receptor (5-HT2AR) P28223 2.00
Cytochrome c/Apaf-2 P00001 2.34
SH2-B Q9NRF1 2.08
DDX1 Q92499 2.84
TFII-I/BAP-135 Q15359 2.05
P140mDia O60610 4.16
Glucocorticoid receptor P04150 2.08
Nup88 Q99567 3.15
E2F2 Q14209 2.46
53BP2 Q13625 3.55
XPA P23035 2.67
M33 P30658 2.89
PCNA P12004 2.26
SCP3 P70281 2.39
Apo E P02649 3.04
CLIP-115 Q9UDT6 2.02
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monolayer and were floating (Fig. 3B,a) while only a
few floating gonocytes were seen in controls (Fig. 3B,b).
After rinsing all chambers, we next quantified and
compared the number of adherent gonocytes in antise-
rum-treated and control cultures (Fig. 3C). We found that
significantly fewer gonocytes were present in the anti-
STPB-C treated cultures compared to controls (P < 0.02).
Finally, apoptosis of gonocytes exposed to anti-STPB-C
or to pre-immune serum was evaluated directly by
immunolocalizing caspase-3 at 4, 10 or 21 h after start
of treatment (Fig. 3D). In the co-cultures treated with
anti-STPB-C at each of the tested times, we detected
many caspase-3-positive cells either singly or in clusters
(panels a,b), while few positive cells occurred in any of
the controls (panels c,d). Based on previously documented
attributes of gonocytes (Orth and Boehm, 1990) such as
nuclear size and adhesion to the underlying monolayer,
most if not all of these apparent apoptotic cells were
judged to be gonocytes. Importantly, anti-STPC-C treat-
ment appeared to leave the underlying Sertoli cell
monolayer unaffected, as judged by the persistence of
confluency and normal cellular morphology in treated
cultures compared to controls (panel a vs. panel c).
Protein microarray analysis of Tg and control rats
To provide prelimary information on proteins whose
expression is potentially linked to STPB-C function, we
used an antibody microarray to compare profiles of
proteins between testes of day 4 old control and Tg
rats. Quantitative analysis of protein expression in the
microarrays and comparison of levels between controls
and Tgs, as described in Materials and methods, indicated
a total of 40 proteins that show significantly increased
expression in testes of Tgs. These proteins are listed in
Table 1. Among the overexpressed proteins in the Tgs,
SH2-B and STAT-3 were of particular interest. Their
increased level of expression was subsequently confirmed
by Western analysis and densitometric quantification (see
Figs. 4B,C). Since SH2-Bh binds to and stimulates the
kinase activity of JAK2 and increases tyrosine phosphor-
ylation of STAT3 and STAT5B (Rui et al., 1997; Rui and
Carter-Su, 1999), our results raised the novel possibility
that STPB-C may activate the JAK-STAT signaling
pathway in neonatal testes. Subsequent experiments were
therefore aimed at testing this possibility.
STPB-C binds to and activates JAK2 and/or SH2-B,
up-regulating STAT3
To determine whether STPB-C activates the JAK-STAT
pathway, we first used immunoprecipitation to clarify
whether SH2-B or JAK2 is an STPB-C binding partner.
Proteins isolated from Tg rat testes were immunoprecipitated
with STPB-C and immunoblotted with anti-SH2-B or anti-JAK2. Each blot was then stripped and re-probed with anti-
STPB-C to confirm the presence of STPB-C. As shown in
Fig. 4A, we found that both SH2-B and JAK2 co-precipitate
with STPB-C, indicating that at least one of these JAK-STAT
pathway components is a binding partner for STPB-C. Next,
to determine whether other JAK-STAT components are also
overexpressed in Tgs, we compared expression of STAT5 and
JAK2 by immunoblotting protein from control and Tg rats
with anti-STAT5 and anti-JAK2 and using densitometry to
quantify differences between the samples. Fig. 4B shows the
Western blots and Fig. 4C the quantitative data from this
analysis. With the latter, we detected a significant increase in
JAK2 expression in Tgs compared to controls (P < 0.01),
while STAT5 was equal in the two groups. Thus, our findings
from both immunoprecipitation analysis and immunoblotting
suggest that STPB-C binds to JAK2 and/or SH2-B, enhanc-
Fig. 4. STPB-C activates the JAK-STAT signaling pathway. (A) Protein obtained from testes of TG rats was immunoprecipitated with STPB-C and then probed
with SH2-B (top panel) or JAK2 (middle panel). Subsequently, blots were stripped and re-probed with anti-STPB-C to confirm the presence of STPB-C in the
immunoprecipitate (e.g., lower panel). (B) Western analysis of SH2-B, STAT3, JAK2, or STAT5 in protein isolated from testes of day 4 transgenic rats (Tg) or
controls (Con). (C) Western blots in panel B were quantified by densitometry and the data were expressed as a ratio of each protein:h-tubulin. This analysis
confirmed overexpression of SH2-B in Tgs compared to controls. In addition, STAT3 and JAK2, but not STAT5, were significantly elevated in Tg rats
compared to controls (*P < 0.01).
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STAT5.
STPB-C activates the JAK-STAT pathway via
phosphorylation of JAK2 and STAT3
We next used gonocyte–Sertoli cell co-cultures to
examine the time course of changes in expression of JAK-Fig. 5. The time course of changes in JAK2 and STAT3 and in their phosphory
Western analysis of p-JAK2, JAK2, p-STAT3, or STAT3 in protein isolated from c
serum (Con). (B) Western blots from each of five replicate sets of cultures were qu
immune serum (Con). Asterisk: P < 0.05 (mean T SEM of five experiments).STAT components following anti-STPB-C treatment for
increasing times (15 min–32 h). As part of this analysis, we
also determined whether STPB-C antiserum caused changes
in levels of phosphorylated JAK-2 and/or STAT3 (Fig. 5).
Densitometric data were obtained and results expressed as a
ratio of signal for treated cells vs. controls (Fig. 5B). By 30
min post-treatment, p-JAK2 was significantly suppressed
and remained decreased through 1 h, returning to normal bylation following anti-STPB-C treatment of co-cultures. (A) Representative
o-cultures 15 min–32 h after exposure to anti-STPB-C (Ab) or pre-immune
antified, and the results were expressed as a ratio of anti-STPB-C (Ab):pre-
Fig. 6. An example of semi-quantitative RT-PCR analysis of transfected L
cells. (A) RT-PCR of mRNA from cells transfected with either pCMV-
STPB-C or empty vector. The expression of GAPDH was used as an
internal standard. M, 1 kb DNA ladder; Mock, empty vector; lanes 1–6,
samples from individual clones transfected with STPB-C. (B) RT-PCR was
semi-quantified by densitometry and the densitometric data were expressed
as a ratio of STPB-C:GAPDH for each sample. Clones exhibiting high
expression of STPB-C mRNA (e.g., *) were used for further experiments.
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albeit somewhat later at 1 h post-treatment, followed by a
return to normal by 4 h through 32 h post-treatment. Thus,
the decrease in phosphorylation of JAK-2 induced by anti-
STPB-C preceded that of STAT3 by about 30 min and also
recovered somewhat more rapidly. In addition, the total
amount of JAK2 was significantly decreased by antiserum
treatment at 4 h post-treatment, while no significant change
was detected in the total pool of STAT3 in the treated
cultures. Thus, blockade of STPB-C in co-cultures sup-
presses overall JAK2 expression, consistent with our
findings from Tg rats where increased STPB-C results in
enhanced JAK2 expression. In addition, direct blockade of
STPB-C in vitro results in reduced phosphorylation of both
JAK2 and STAT3 in a temporal pattern consistent with the
known sequence of these pathway components (Aaronson
and Horvath, 2002).
Conversely, to establish that expression of STPB-C is
sufficient to up-regulate the JAK-STAT pathway under
conditions which alter cell function, we transfected L
cells which lack endogenous cadherins (Sugimoto et al.,
1996) with a construct containing STPB-C cDNA
(pCMV-STPB-C). Stable transformants were isolated by
screening with G418 and expression of STPB-C was
examined by semi-quantitative RT-PCR (Fig. 6). Clones
exhibiting high expression of STPB-C mRNA were used
for further experiments. Individual transfected cells
appeared morphologically similar to parental cells and
Northern and Western blot analyses showed a band of
predicted size in the cells transfected with the STPB-C
expression vector (Fig. 7), indicating expression of
apparently normal STPB-C by the transfected cultures.
Next, to determine whether transfection with STPB-C
produced functional, Ca2+-dependent cell–cell adhesion
in the transfected cultures, a cell aggregation assay was
performed. STPB-C-transfected, mock-transfected (plas-
mid only), or parental monolayers were trypsinized to
provide single cells and the resulting cells were
incubated T1 mM CaCl2 to allow the potential formation
of cellular aggregates. We found that only the STPB-C-
transfected cells formed aggregates, and only if Ca2+ was
present in the incubation media (Fig. 8). Aggregates
were of various size, containing from 2 or 3 cells to
large numbers of cells. No aggregates were seen in any
other incubations, including that with transfected cells in
the absence of Ca2+. Thus, transfection of L cells with
STPB-C induced functional cadherin-mediated adhesion.
Finally, we determined whether STPB-C transfection
of L cells produced up-regulation of JAK-STAT compo-
nents, parallel to the down-regulation we had observed in
anti-STPB-C treated testicular co-cultures. For this, we
compared both total expression and phosphorylation
levels of JAK2 and STAT3 in STPB-C-transfected and
mock-transfected L cells (Figs. 7C,D). We found that
phosphorylation of both JAK2 and STAT3 were substan-
tially increased (P < 0.001) in transfected cells comparedto controls. In addition, there was also an increase in
total JAK2 (P < 0.005) in the transfected cultures, results
paralleling exactly our findings in anti-STPB-C treated
co-cultures. Taken together, our observations on trans-
fected L cells, along with our findings from transgenic
rats and from anti-STPB-C treated co-cultures, indicate
that STPB-C activates the JAK-STAT signaling pathway
by inducing phosphorylation of JAK2 and STAT3.Discussion
In adult rodents, the number of differentiating sperma-
togonia available to enter spermatogenesis is controlled
by regulation of both proliferation and cell death of their
ancestors, the self-renewing Type A spermatogonia
(Sharpe, 1994). Continuous availability of these sperma-
togonia is responsible for lifelong fertility of males. In
this study, we examined a rare cadherin, STPB-C,
previously found by us to be highly expressed in
neonatal testes (Wu et al., 2003), asking whether it has
a role in promoting survival of gonocytes which are the
progenitors in neonates of the first generations of
spermatogonia that develop at puberty. First, we found
that overexpression of this factor in transgenic rats
Fig. 7. (A) Northern analysis of STPB-C mRNA and (B) Western analysis of STPB-C protein in stably transfected L cells, confirming their expression of
STPB-C compared to mock-transfected cells. (C) Western analysis of p-JAK2, JAK2, p-STAT3, or STAT3 in samples obtained from mock-transfected or
STPB-C transfected L cells. (D) Western blots in panel C were quantified by densitometry and the data were expressed as a ratio of protein:h-tubulin for each.
Expression of p-JAK2 (*P > 0.001), total JAK2 (*P > 0.005), and p-STAT3 (*P > 0.001) was significantly elevated in transfected L cells compared to mock-
transfected controls.
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neonates. Although we cannot as yet rule out a prenatal
effect of high STPB-C in these transgenics, perhaps
influencing germ cell proliferation in fetuses, we did find
that STPB-C overexpression was accompanied by an
apparent absence of post-natal apoptosis in this popula-
tion. Thus, it is likely that reduced apoptosis is at least
partly responsible for the elevated numbers of gonocytes
in transgenic pups. This likelihood is also supported by
our observation that blockade of endogenous STPB-C in
testicular co-cultures prepared from normal neonates
resulted in a substantial increase in caspase-3 positive
gonocytes compared to controls. With longer incubation
in STPB-C antiserum, we also observed detachment of
large numbers of gonocytes from the underlying Sertoli
cells. Thus, expression of STPB-C in neonates appears to
support gonocyte survival by suppressing apoptosis.Formation of a germ cell population of appropriate size
during testicular development is critical in establishing
spermatogenesis and insuring fertility at adulthood, and this
seems to be partly determined by an early and large wave of
germ cell apoptosis (Rodriguez et al., 1997). For example,
mis-expression of the death repressor gene Bcl-2 in 2-week-
old mice leads to abnormally high numbers of spermatogo-
nia and results in disrupted spermatogenesis (Furuchi et al.,
1996), while knocking out the Bax gene produces a similar
disruption of spermatogenesis and infertility in adult mice
(Knudson et al., 1995). Both lines of evidence highlight the
need for apoptosis to reduce the numbers of early
spermatogenic cells to appropriate levels. However, to date,
essentially nothing is known about the mechanisms whereby
some gonocytes avoid apoptosis and survive to become
founders of the spermatogonial population. Our current data
suggest that at least one requirement for gonocytes to
Fig. 8. Cell aggregation assay of STPB-C transfected L cells. (A) Representative view of a cell aggregation assay performed on mock-transfected (left) and
STPB-C transfected (right) cells. Both small and large cellular aggregates formed only in the STPB-C transfected cells in the presence of Ca2+. Arrows indicate
examples of large cell aggregates. (B) Quantification and Ca2+-dependence of cell aggregation in STPB-C transfected L cells vs. mock-transfected or parental L
cells. Equal numbers of cells were added to each incubation at the start of the experiment. Aggregation index (N25/N0) is the ratio of the total number of
particles in the cell suspension after 25 min incubation (N25) to the number of particles at the start of the incubation (N0), with or without 1 mM CaCl2.
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some of these cells to avoid apoptosis while others
expressing little or no STPB-C are destined to die.
Although we have not yet fully evaluated the adult testis
in transgenic rats overexpressing STPB-C, our preliminary
data indicate that these males are fertile and that they have
testes of overall normal morphology (data not shown). This
is an interesting observation considering our finding that
abnormally high numbers of gonocytes were present in
neonatal transgenics. Since a complete analysis of the
transgenic rats throughout further development and puberty
was beyond the scope of the present work, at this time, we
can only speculate on the basis for normal fertility in these
animals as adults. Little is known about mechanisms that
determine survival of germ cells as the testis develops
beyond the neonatal period. However, it is clear from othermodels that long term suppression of germ cell apoptosis is
detrimental to fertility. For example, in the Bax knockout
mouse, suppression of germ cell apoptosis leads to lifelong
interference with the normal occurrence of germ cell
apoptosis, producing enormous numbers of spermatogonia
in young animals, followed by structural abnormalities in
the seminiferous tubules and subsequent infertility in adults
(Knudson et al., 1995). However, although STPB-C over-
expression also seems to suppress apoptosis, the mecha-
nism whereby this happens is doubtless quite different than
that following direct suppression of a ‘‘death’’ gene such as
Bax since STPB-C is a cadherin most likely involved in
cellular interactions. In addition, our earlier work (Wu et
al., 2003) demonstrated that STPB-C expression is highest
during perinatal development, dropping significantly to
very low levels in adults. Thus, overexpression of STPB-C
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in neonates, with subsequent overexpression of potentially
less consequence later in life when the protein has less
significance. In addition, other as yet unknown mecha-
nisms may operate during prepubertal development to
adjust germ cell numbers in these animals. Additional
studies are planned with the transgenic model, including a
detailed morphometric analysis of cell numbers in semi-
niferous tubules of adults, and the outcome of these and
other studies will clarify in more detail the impact of
STPB-C overexpression both later development and in
adults.
Our observations on STPB-C also provide additional
new evidence highlighting the critical relationship between
Sertoli cells and germ cells in neonatal development. STPB-
C is expressed in both cell types (Wu et al., 2003) and
blockade of its expression in co-cultured cells results in up-
regulation of caspase-3 in gonocytes, followed by eventual
detachment of gonocytes from Sertoli cells with no apparent
changes in the somatic cells. Thus, expression of STPB-C is
required for normal adhesion and functional interaction
between these cell types in neonates. While alteration in
STPB-C expression appears to affect gonocytes without
obvious changes in Sertoli cells, our data on signaling
events triggered by STPB-C, discussed below, were
obtained from testicular homogenates. This leaves open
the possibility that STPB-C expression may also be critical
for neonatal Sertoli cell function beyond maintaining their
adhesion with germ cells, a possibility we will explore in
future studies.
Our findings demonstrate, for the first time, a functional
link between cadherin-mediated cell behavior and the JAK-
STAT pathway. This was first suggested by the outcome of
protein microarrays performed on normal and transgenic
rats. Since our previous data indicated that Thyroid
Hormone is not involved in STPB-C function (Wu et al.,
2003) and that gonadotropin levels are normal in transgenics
(data not shown), we sought clues to regulatory pathways
for STPB-C by using a microarray. The resulting suggestion
that JAK-STAT components are involved in STPB-C action
was later confirmed by several approaches, revealing up-
regulation of JAK2, STAT3, and SH2-B in transgenics and
down-regulation of these components in cultured cells
exposed to anti-STPB-C. In addition, our studies on L cells
transfected with STPB-C confirmed that ectopic expression
of this protein is associated with increased JAK-STAT
activity and is also accompanied by cell–cell adhesion that
is consistent with cadherin-based function. Taken together,
these observations provide strong evidence supporting the
concept that STPB-C activates this important pathway.
In mammals, the JAK-STAT pathway is the principal
signaling mechanism for a wide array of cytokines and
growth factors and STAT3 has been shown to have a central
role in suppressing apoptosis. For example, normal T cells
that no longer express STAT3 are insensitive to the anti-
apoptotic effects of IL-6 (Takeda et al., 1998) and theconstitutively-expressed form of STAT3 (STAT3-C) in-
creases resistance to apoptotic challenges (Shen et al.,
2001). Moreover, in many cancers including lymphomas,
leukemias, multiple myeloma, breast, and others, STAT3 has
been found to be persistently activated (Bowman et al.,
2000). Thus, our observations of up-regulation of STAT3 in
transgenics and in transfected L cells and its down-
regulation in antibody treated cells, with no changes in
STAT5, are consistent with a similar role for STAT3 in
regulation of apoptosis in testicular gonocytes. Similarly,
our finding of increased SH2-B in transgenic rats is also
consistent with current understanding of this signaling
molecule. SH2-B mediates the effects of a number of
factors that regulate cell survival and proliferation, including
growth hormone, insulin, insulin-like growth factor, nerve
growth factor, and platelet-derived growth factor (PDGF).
Interestingly, PDGF has been identified as a regulator of
gonocyte proliferation in neonatal rats (Li et al., 1997),
raising the possibility that it may also activate the JAK-
STAT pathway in exerting this effect, a possibility that
remains to be explored.
In summary, we have identified STPB-C as an important
factor determining the fate of gonocytes in neonatal rats. Its
expression in neonates may allow these cells to avoid
apoptosis and may also have a role in maintaining proper
adhesion with Sertoli cells. We have also demonstrated that
STPB-C activates the JAK-STAT pathway by inducing
phosphorylation of JAK2 and subsequently of STAT3,
implying that STAT3 may prevent apoptosis in these cells
as it does in many other systems (Shen et al., 2001; Catlett-
Falcone et al., 1999). Thus, our observations identify a new
and potentially exciting link among cadherin-mediated
cell–cell adhesion, the JAK-STAT pathway and gonocyte
apoptosis, indicating that this pathway is operational in the
neonatal testis where regulation of germ cell survival is
especially critical (Kiger et al., 2001; Tulina and Matunis,
2001).Acknowledgment
This work was supported by NIH Grant HD-15563 (to
J.M.O.).References
Aaronson, D.S., Horvath, C.M., 2002. A road map for those who don’t
know JAK-STAT. Science 296, 1653–1655.
Bowman, T., Garcia, J., Turkson, J., Jove, R., 2000. STATs in oncogenesis.
Oncogene 19, 2474–2488.
Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki,
A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J., Nunez,
G., et al., 1999. Constitutive activation of Stat3 signaling confers
resistance to apoptosis in human U266 myeloma cells. Immunity 10,
105–115.
Furuchi, T., Masuko, K., Nishimune, Y., Obinata, M., Matsui, Y., 1996.
Inhibition of testicular germ cell apoptosis and differentiation in
J. Wu et al. / Developmental Biology 284 (2005) 437–450450mice misexpressing Bcl-2 in spermatogonia. Development 122,
1703–1709.
Griswold, M., 1995. Interactions between germ cells and Sertoli cells in the
testis. Biol. Reprod. 52, 211–216.
Kiger, A., Jones, D., Schulz, D., Rogers, M., Fuller, M., 2001. Stem cell
self-renewal specified by JAK-STAT activation in response to a support
cell cue. Science 294, 2542–2545.
Knudson, C.M., Tung, K.S., Tourtellotte, W., Brown, G., Korsmeyer, S.,
1995. Bax-deficient mice with lymphoid hyperplasis and male germ cell
death. Science 270, 96–99.
Li, H., Papadopoulos, V., Vidic, B., Dym, M., Culty, M., 1997. Regulation
of rat testis gonocyte proliferation by platelet-derived growth factor
and estradiol: identification of signaling mechanisms involved.
Endocrinology 138, 1289–1298.
McGuinness, M., Orth, J.M., 1992. Reinitiation of gonocyte mitosis and
movement of gonocytes to the basement membrane in testes of newborn
rats in vivo and in vitro. Anat. Rec. 233, 527–537.
Orth, J.M., Boehm, R., 1990. Functional coupling of neonatal rat Sertoli
cells and gonocytes in culture. Endocrinology 127, 2812–2820.
Orth, J.M., Jester, W.F., Qiu, J., 1996. Gonocytes in testes of neonatal rats
express the c-kit gene. J. Mol. Reprod. Dev. 45, 123–131.
Orth, J.M., Jester, W., Li, L.-H., Laslett, A., 2000. Gonocyte–Sertoli cell
interactions during development of the neonatal rodent testis. Curr. Top.
Dev. Biol. 50, 103–123.
Rodriguez, I., Ody, C., Araki, K., Garcia, I., Vassali, P., 1997. An early and
massive wave of germinal cell apoptosis is required for the development
of functional spermatogenesis. EMBO J. 16, 2262–2270.
Rui, L., Carter-Su, C., 1999. Identification of SH2-beta as a potent
cytoplasmic activator of the tyrosine kinase Janus Kinase 2. Proc. Natl.
Acad. Sci. U. S. A. 96, 7172–7177.Rui, L., Mathews, L.S., Hotta, K., Gustafson, T.A., Carter-Su, C., 1997.
Identification of SH2-Bbeta as a substrate of the tyrosine kinase
JAK2 involved in growth hormone signaling. Mol. Cell. Biol. 17,
6633–6644.
Sharpe, R., 1994. Regulation of spermatogenesis. In: Knobil, E., Neill,
J.D. (Eds.), The Physiology of Reproduction. Raven Press, New York,
pp. 1363–1434.
Shen, Y., Devgan, D., Darnell Jr., J.E., Bromberg, J.F., 2001.
Constitutively activated Stat3 protects fibroblasts from serum with-
drawal and UV-induced apoptosis and antagonizes the proapoptotic
effects of activated Stat1. Proc. Natl. Acad. Sci. U. S. A. 98,
1543–1548.
Sugimoto, K., Honda, S., Yammamoto, T., Ueki, T., Monden, M., Kaji, A.,
Matsumoto, K., Nakamura, T., 1996. Molecular cloning and character-
ization of a newly identified member of the cadherin family, PB-
cadherin. J. Biol. Chem. 271, 11548–11556.
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., Akira,
S., 1998. Stat3 activation is responsible for IL-6-dependent T cell
proliferation through preventing apoptosis: generation and character-
ization of T cell-specific Stat3-deficient mice. J. Immunol. 161,
4652–4660.
Takeichi, M., 1977. Functional correlation between cell adhesive properties
and some cell surface proteins. J. Cell Biol. 75, 464–474.
Tulina, N., Matunis, E., 2001. Control of stem cell self-renewal in
Drosophila spermatogenesis by JAK-STAT signalling. Science 294,
2546–2549.
Wu, J., Jester, W.F., Laslett, A.L., Meinhardt, A., Orth, J.M., 2003.
Expression of a novel factor, short-type PB-cadherin, in Sertoli cells and
spermatogenic stem cells of the neonatal rat testis. J. Endocrinol. 176,
381–391.
